[]
Yokosawa M., Hayashi T., Shirane R., et al.: Efficacy of Superficial
Temporal Artery-Middle Cerebral Artery Double Anastomoses in
a Patient with Rapidly Progressive Moyamoya Disease: Case Report.
Neurol Med Chir (Tokyo). 2014 Feb 28. (E-publ. ahead of print).
[]
Kuroda S., Kamiyama H., Isobe M., et al.: Cerebral hemodynamics and
„re-build-up“ phenomenon on electroencephalogram in children with
moyamoya disease. Childs Nerv Syst 1995 Apr; 11(4): 214–9.
[]
Kuwabara Y., Ichiya Y., Sasaki M., et al. Cerebral hemodynamics and
metabolism in moyamoya disease--a positron emission tomography
study. Clin Neurol Neurosurg 1997 Oct; 99 Suppl 2: S74–8.
[]
Horowitz M., Yonas H., Albright A.L.: Evaluation of cerebral blood flow
and hemodynamic reserve in symptomatic moyamoya disease using
stable Xenon-CT blood flow. Surg Neurol 1995; 44: 251.
[]
Matsushima Y., Inaba Y.: Moyamoya disease in children and its surgical
treatment. Introduction to surgical procedure and follow-up angiograms.
Child‘s Brain 1984; 11: 155.
[]
Golby A.J., Marks M.P., Thompson R.C., et al.: Direct and combined
revascularization in pediatric moyamoya disease. Neurosurgery 1999;
45: 50.
[]
Kennedy B.C., McDowell M.M., Yang P.H., et al. Pial synangiosis
for moyamoya syndrome in children with sickle cell anemia:
a comprehensive review of reported cases. Neurosurg Focus 2014 Jan;
36(1).
[]
Matsushima T., Inoue T.K., Suzuki S.O., et al.: Surgical techniques and the
results of a fronto-temporo-parietal combined indirect bypass procedure
for children with moyamoya disease: a comparison with the results of
encephalo-duro-arterio-synangiosis alone. Clin Neurol Neurosurg 1997
Oct; 99 Suppl 2: S123–7.
[]
Funaki T., Takahashi J.C., Takagi Y., et al. Incidence of late cerebrovascular
events after direct bypass among children with moyamoya disease:
a descriptive longitudinal study at a single center. Acta Neurochir (Wien)
2014 Mar; 156(3): 551–559.
[]
Kodama N., Aoki Y., Hiraga H., et al.: Electroencephalographic findings in
children with moyamoya disease. Neurol 1979; 36: 16.
[]
Navarro R., Chao K., Gooderham P.A., et al.: Less invasive pedicled
omental-cranial transposition in pediatric patients with moyamoya
disease and failed prior revascularization. Neurosurgery 2014 Mar; 10
Suppl 1: 1–14.
[]
Scott R.M., Smith J..L, Robertson R.L., et al. Long-term outcome in
children with moyamoya syndrome after cranial revascularization by pial
synangiosis. J Neurosurg 2004 Feb; 100 (2 Suppl Pediatrics): 142–149.
[]
McLaughlin N., Martin N.A.: Effectiveness of Burr Holes for Indirect
Revascularization in Patients with Moyamoya Disease-A Review of the
Literature. World Neurosurg 2014 Jan; 81: 91–98.
[]
Hankinson T.C., Bohman L.E., Heyer G., et al.: Surgical treatment of
moyamoya syndrome in patients with sickle cell anemia: outcome
following encephaloduroarteriosynangiosis. J Neurosurg Pediatr 2008
Mar; 1(3): 211–216.
[]
Kansha M., Irita K., Takahashi S., et al. Anesthetic management of
children with moyamoya disease. Clin Neurol Neurosurg 1997 Oct; 99
Suppl 2: 110–113.
[]
Ilkhchoui Y., Panikkath P.V., Martin H.: Moyamoya disease,
revascularisation surgery and anaesthetic considerations. BMJ Case
Rep 2014; Jan 8: 2014.
[]
Fujimura M., Niizuma K., Inoue T., et al.: Minocycline prevents
focal neurological deterioration due to cerebral hyperperfusion after
extracranial-intracranial bypass for moyamoya disease. Neurosurgery
2014 Feb; 74: 163–170.
[]
Borowik H., Pogorzelski R., Drozdowski W.: Choroba moyamoya jako
przyczyna udaru niedokrwiennego mózgu w młodym wieku. Przegl Lek
2006; 3: 6910–6914.
[]
Natori Y., Ikezaki K., Matsushima T., et al.: ‚Angiographic moyamoya‘ its
definition, classification, and therapy. Clin Neurol Neurosurg 1997 Oct;
99 Suppl 2: 168–172.
[]
Matsushima Y., Qian L., Aoyagi M.: Comparison of moyamoya disease in
Japan and moyamoya disease (or syndrome) in the People‘s Republic of
China. Clin Neurol Neurosurg 1997 Oct; 99 Suppl 2: 19–22.
[]
Scott M.R., Smith E.R.: Moyamoya disease and moyamoya syndrome.
New England Journal of Medicine 2009; 360: 1226–1237.
[]
Kuriyama S., Kusaka Y., Fujimura M. et al.: Prevalence and
clinicoepidemiological features of moyamoya disease in Japan: findings
from a nationwide epidemiological survey. Stroke 2008; 39: 4–7.
[]
Hallemeier C., Rich K., Brubb R., Chicoine M., et al.: Epidemiological
features of moyamoya disease in Japan: findings from a nationwide
survey. Stroke 2006; 37: 1490–1496.
[]
Inoue T.K., Ikezaki K., Sasazuki T., et al. Analysis of class II genes of
human leukocyte antigen in patients with moyamoya disease. Clin
Neurol Neurosurg 1997 Oct; 99 Suppl 2: 234–237.
[]
Tsuda H., Hattori S., Tanabe S., et al. Thrombophilia found in patients
with moyamoya disease. Clin Neurol Neurosurg 1997 Oct; 99 Suppl 2:
229–233.
[]
Jiang T., Perry A., Dacey R.G. Jr. et al.: Intracranial atherosclerotic disease
associated with moyamoya collateral formation: histopathological
findings. J Neurosurg 2013; 118: 1030–1034.
[]
Sato M., Kohama A., Fukuda A., et al.: Moyamoya-like disease associated
with ventricular hemorrhage. A report of three cases. Neurosurg 1985;
17: 260.
[]
Aoyagi M., Fukai N., Yamamoto M. et al.: Development of intimal
thickening in superficial temporal arteries in patients with moyamoya
disease. Clin Neurol Neurosurg 1997 Oct; 99: 213–217.
[]
Suzuki I., Kodama N.: Moyamoya disease: a review. Stroke 1983; 14:
104.
[]
Suzuki I., Takaku A.: Cerebrovascular „moyamoya” disease: disease
showing abnormal net-like vessels of the brain. Arch Neurol 1969; 20:
288.
[]
Pilarska E.: Udar niedokrwienny u dzieci: czynniki ryzyka, objawy,
leczenie, następstwa. Neurol Pol 2009; v. 18 nr 36: 13–18.
[]
Kułakowska A., Kapica-Topczewska K., Borowik H., et al.: Choroba
moyamoya jako rzadka przyczyna udaru niedokrwiennego mózgu – opis
przypadku. Pol Merk Lek 2009; XXVII; 160: 334–
337.
[]
Kaczorowska M., Jóźwiak S., Litwin M., et al.: Choroba moyamoya
współistniejąca ze zwężeniem tętnic pozaczaszkowych – opis przypadku
i przegląd piśmiennictwa. Neurol Neurochir Pol 2005; 39: 242–246.
Scholar Google
PubMed